These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16553491)

  • 1. Daptomycin: the first approved lipopeptide antimicrobial.
    Guay DR
    Consult Pharm; 2004 Jul; 19(7):614-28. PubMed ID: 16553491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daptomycin: a cyclic lipopeptide antimicrobial agent.
    Jeu L; Fung HB
    Clin Ther; 2004 Nov; 26(11):1728-57. PubMed ID: 15639687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daptomycin in bone and joint infections: a review of the literature.
    Rice DA; Mendez-Vigo L
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daptomycin: a review 4 years after first approval.
    Sauermann R; Rothenburger M; Graninger W; Joukhadar C
    Pharmacology; 2008; 81(2):79-91. PubMed ID: 17940348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer treatment options for skin and soft tissue infections.
    Raghavan M; Linden PK
    Drugs; 2004; 64(15):1621-42. PubMed ID: 15257625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linezolid for the treatment of resistant gram-positive cocci.
    Bain KT; Wittbrodt ET
    Ann Pharmacother; 2001 May; 35(5):566-75. PubMed ID: 11346064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daptomycin: a novel agent for Gram-positive infections.
    Tally FP; Zeckel M; Wasilewski MM; Carini C; Berman CL; Drusano GL; Oleson FB
    Expert Opin Investig Drugs; 1999 Aug; 8(8):1223-38. PubMed ID: 15992147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.
    Steenbergen JN; Alder J; Thorne GM; Tally FP
    J Antimicrob Chemother; 2005 Mar; 55(3):283-8. PubMed ID: 15705644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of multiresistant Gram positive endocarditis].
    Utili R
    Infez Med; 2009 Jul; 17 Suppl 3():13-24. PubMed ID: 19838095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tigecycline: a glycylcycline antimicrobial agent.
    Doan TL; Fung HB; Mehta D; Riska PF
    Clin Ther; 2006 Aug; 28(8):1079-1106. PubMed ID: 16982286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens.
    Carpenter CF; Chambers HF
    Clin Infect Dis; 2004 Apr; 38(7):994-1000. PubMed ID: 15034832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Daptomycin: a novel cyclic lipopeptide antimicrobial.
    Schriever CA; Fernández C; Rodvold KA; Danziger LH
    Am J Health Syst Pharm; 2005 Jun; 62(11):1145-58. PubMed ID: 15914875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
    Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)].
    Loza E; Morosini MI; Pascual A; Tubau F; Alcalá J; Liñares J; Hernández-Bello JR; Baquero F; Perea E; Martín R; Jones RN; Cantón R;
    Enferm Infecc Microbiol Clin; 2008 Oct; 26(8):489-94. PubMed ID: 19094861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daptomycin.
    Fenton C; Keating GM; Curran MP
    Drugs; 2004; 64(4):445-55; discussion 457-8. PubMed ID: 14969579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS; Watters AA; Fritsche TR; Jones RN
    BMC Infect Dis; 2007 Apr; 7():29. PubMed ID: 17442104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopeptides, focusing on daptomycin, for the treatment of Gram-positive infections.
    Eisenstein BI
    Expert Opin Investig Drugs; 2004 Sep; 13(9):1159-69. PubMed ID: 15330747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid: an oxazolidinone antimicrobial agent.
    Fung HB; Kirschenbaum HL; Ojofeitimi BO
    Clin Ther; 2001 Mar; 23(3):356-91. PubMed ID: 11318073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment options for vancomycin-resistant enterococcal infections.
    Linden PK
    Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.